Reuters logo
4 months ago
BRIEF-Medivir announces positive phase II study data, shares rise
April 7, 2017 / 10:42 AM / 4 months ago

BRIEF-Medivir announces positive phase II study data, shares rise

April 7 (Reuters) - Medivir AB

* Says announces positive data from the phase II study of remetinostat in patients with early-stage cutaneous T-cell lymphoma

* Says based on these data, Medivir expects to initiate discussions with regulatory authorities with the aim of initiating a phase III study later this year, and to present full phase II trial data at scientific meetings in the second half of 2017

* Medivir shares rise 5 pct at 10:36 GMT, on the way to the strongest daily performance in 2017 Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below